Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Helen X. Chen, M.D.

Associate Branch Chief, Immunooncology

Investigational Drug Branch

NCI DCTD Cancer Therapy Evaluation Program

240-276-6565

Helen.chen@nih.gov

Dr. Helen Chen joined NCI’s Cancer Therapy Evaluation Program (CTEP) in 2000. She currently serves as Associate Chief of Immuno-oncology for the Investigational Drug Branch (IDB), leading activities related to the clinical development of new cancer immunotherapy agents and therapeutic antibodies. Dr. Chen is board-certified in Medical Oncology after completing her Fellowship training at Georgetown University Medical Center in Washington D.C.